MARKET

SVRA

SVRA

Savara
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.430
-0.090
-3.57%
After Hours: 2.430 0 0.00% 16:00 09/19 EDT
OPEN
2.590
PREV CLOSE
2.520
HIGH
2.590
LOW
2.430
VOLUME
240.97K
TURNOVER
--
52 WEEK HIGH
11.96
52 WEEK LOW
2.110
MARKET CAP
100.11M
P/E (TTM)
-1.5633
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SVRA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

SVRA News

  • Savara to Present Comprehensive Data From Pivotal Phase 3 IMPALA Study at 2019 ERS
  • Business Wire.1d ago
  • Mangrove Partners Return, AUM, and Holdings
  • Insider Monkey.09/02 16:39
  • The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission
  • Benzinga.08/16 11:33
  • Savara (SVRA) Investor Presentation - Slideshow
  • Seeking Alpha - Article.08/15 19:35

More

Industry

Biotechnology & Medical Research
+0.01%
Pharmaceuticals & Medical Research
+0.41%

Hot Stocks

Name
Price
%Change

About SVRA

Savara Inc., formerly Mast Therapeutics, Inc., is an orphan lung disease company. The Company is engaged in the development and commercialization of novel therapeutics to address unmet medical needs. Its product pipeline include Molgradex, AeroVanc and Aironite. Molgradex is an inhaled formulation of recombinant human GM-CSF. It is developing Molgradex for the treatment of pulmonary alveolar proteinosis (PAP) and nontuberculous mycobacterial (NTM) lung infection. AeroVanc is a vancomycin hydrochloride inhalation powder. It is developing AeroVanc as an antibiotic for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) lung infection in individuals living with cystic fibrosis (CF). Aironite is a sodium nitrite inhalation solution. Aironite is an investigational product. The Company is developing Molgradex in a pivotal Phase-III clinical trial for the treatment of PAP and in a Phase II a study for NTM lung infection. AeroVanc is in a Phase-III clinical trial.
More

Webull offers Savara Inc (SVRA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.